HomeOwner SearchCategory Search
Visit USCODifferentiating myelodysplastic syndrome (MDS) and acute myelocytic leukemia (AML) Kathleen Finnegan, 1954
Text Registration
Copyright Title
Differentiating myelodysplastic syndrome (MDS) and acute myelocytic leukemia (AML) Kathleen Finnegan, 1954
Status
Published
on 14 Jun 2007
Year of Creation
1998
Copyright Claimant
American Society of Clinical Pathologists
Registration Number
TX0004917153
on 14 Jun 2007Copyright Summary
The U.S. Copyright record (Registration Number: TX0004917153) dated 14 Jun 2007, pertains to an electronic file (eService) titled "Differentiating myelodysplastic syndrome (MDS) and acute myelocytic leukemia (AML) Kathleen Finnegan, 1954" created in 1998. The copyright holder is American Society of Clinical Pathologists, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to American Society of Clinical Pathologists.
Application Details
Registration Number
TX0004917153
Registration Date
6/14/2007
Year of Creation
1998
Agency Marc Code
DLC-CO
Record Status
New
Physical Description
p. 36-43
Series Statement
Tech Sample Hematology no. H-6 (1998
Statements
Application Title Statement: Tech Sample : no. H-6 (1998) ; Differentiating MDS & AML
© 2024 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.